Αποτελέσματα Αναζήτησης
20 Μαΐ 2024 · Generic name: norelgestromin and ethinyl estradiol. Dosage form: patch, extended release. Drug class: Contraceptives. Medically reviewed by Drugs.com. Last updated on May 20, 2024. The Ortho Evra brand name has been discontinued in the U.S.
6 Φεβ 2023 · What are the ingredients in ORTHO EVRA? Active ingredient: norelgestromin and ethinyl estradiol. Inactive ingredient: polyethylene, polyester, polyisobutylene/polybutene adhesive, crospovidone, non-woven polyester fabric, lauryl lactate, polyethylene terephthalate (PET) film, and polydimethylsiloxane coating.
DESCRIPTION. ORTHO EVRA® is a combination transdermal contraceptive patch with a contact surface area of 20 cm2. It contains 6.00 mg norelgestromin (NGMN) and 0.75 mg ethinyl estradiol (EE).
Overview. This is a summary of the European public assessment report (EPAR) for Evra. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Evra.
30 Δεκ 2023 · Generic name: ethinyl estradiol and norelgestromin [ nor-el-JES-troe-min, ETH-i-nil-es-tra-DYE-ol ] Brand names: Ortho Evra, Xulane Drug class: Contraceptives. Medically reviewed by Drugs.com. Last updated on Dec 30, 2023. Uses. Before taking. Dosage. Warnings. Side effects. Brand names. FAQ.
SUMMARY OF PRODUCT CHARACTERISTICS. 1. NAME OF THE MEDICINAL PRODUCT. EVRA 203 micrograms/24 hours + 33.9 micrograms/24 hours transdermal patch. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION. Each 20 cm2 transdermal patch contains 6 mg norelgestromin (NGMN) and 600 micrograms ethinyl estradiol (EE).
A combination of fexofenadine HCl and pseudoephedrine HCl in an extended-re-lease tablet (60 mg/120 mg) is indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and chil-dren 12 years and older. For more infor-mation, contact Barr Pharmaceuticals Inc. by calling 800-222-0190 or 201-930-3302.
